Ionis Says EU Committee Recommends Expanded Tryngolza Approval
Ionis Pharmaceuticals said the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended expanded approval of Tryngolza for people with severe hypertriglyceridemia.